Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Christopher Barnes and Pamela Bjorkman.
Christopher Barnes
Connection Strength
3.809
Pamela Bjorkman
  1. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature. 2020 12; 588(7839):682-687.
    View in: PubMed
    Score: 0.908
  2. Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies. Cell. 2020 08 20; 182(4):828-842.e16.
    View in: PubMed
    Score: 0.889
  3. Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelope. Nat Commun. 2018 03 28; 9(1):1251.
    View in: PubMed
    Score: 0.761
  4. Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York. Nat Commun. 2021 08 09; 12(1):4886.
    View in: PubMed
    Score: 0.240
  5. Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice. Science. 2021 02 12; 371(6530):735-741.
    View in: PubMed
    Score: 0.231
  6. Partially Open HIV-1 Envelope Structures Exhibit Conformational Changes Relevant for Coreceptor Binding and Fusion. Cell Host Microbe. 2018 10 10; 24(4):579-592.e4.
    View in: PubMed
    Score: 0.197
  7. Publisher Correction: Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice. Nature. 2021 Sep; 597(7874):E2.
    View in: PubMed
    Score: 0.060
  8. Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations. Immunity. 2021 08 10; 54(8):1853-1868.e7.
    View in: PubMed
    Score: 0.060
  9. Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies. Nat Commun. 2021 07 07; 12(1):4196.
    View in: PubMed
    Score: 0.060
  10. B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV. Cell. 2021 06 10; 184(12):3205-3221.e24.
    View in: PubMed
    Score: 0.059
  11. Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice. Nature. 2021 05; 593(7859):424-428.
    View in: PubMed
    Score: 0.059
  12. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature. 2021 04; 592(7855):616-622.
    View in: PubMed
    Score: 0.058
  13. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021 03; 591(7851):639-644.
    View in: PubMed
    Score: 0.058
  14. Structural biology in the fight against COVID-19. Nat Struct Mol Biol. 2021 01; 28(1):2-7.
    View in: PubMed
    Score: 0.058
  15. De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2. Science. 2020 12 04; 370(6521):1208-1214.
    View in: PubMed
    Score: 0.057
  16. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature. 2020 08; 584(7821):437-442.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.